Trial Profile
A open label, single arm multicenter study investigating the effect of bevacizumab + 5-fluorouracil, irinotecan, and leucovorin in patients from China with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 06 Dec 2015 New trial record